X0306 4 2019-02-19 0 0001750019 TCR2 THERAPEUTICS INC. TCRR 0001575745 Jovan-Embiricos Morana C/O TCR2 THERAPEUTICS INC. 100 BINNEY STREET CAMBRIDGE MA 02142 1 0 1 0 0001600769 Globeways Holdings Ltd 3RD FLOOR, GENEVE PLACE, WATERFRONT DR PO BOX 3175, ROAD TOWN, TORTOLA, BVI CH-1205 GENEVA V8 SWITZERLAND 0 0 1 0 0001768161 Globeways Holdings II Ltd 3RD FLOOR, GENEVE PLACE, WATERFRONT DR PO BOX 3175, ROAD TOWN TORTOLA, BVI CH-1205 GENEVA V8 SWITZERLAND 0 0 1 0 0001767391 F2 Capital I 2015 Ltd C/O LJ PARTNERSHIP, 8, RUE SAINT-LEGER, GENEVA V8 CH-1205 SWITZERLAND 0 0 1 0 0001767388 F2 Bioscience II 2017 Ltd C/O LJ PARTNERSHIP, 8, RUE SAINT-LEGER, GENEVA V8 CH-1205 SWITZERLAND 0 0 1 0 0001767390 F2 Captial I 2017 Ltd C/O LJ PARTNERSHIP, 8, RUE SAINT-LEGER, GENEVA V8 CH-1205 SWITZERLAND 0 0 1 0 0001767396 F2 MG Ltd C/O LJ PARTNERSHIP, 8, RUE SAINT-LEGER, GENEVA V8 CH-1205 SWITZERLAND 0 0 1 0 0001767397 F2 - TPO Investments LLC C/O LJ PARTNERSHIP, 8, RUE SAINT-LEGER, GENEVA V8 CH-1205 SWITZERLAND 0 0 1 0 0001767415 F2 BBG LLC C/O SINGER MCKEON INC, 8 WEST 38TH ST SUITE 1001 NEW YORK NY 10018 0 0 1 0 0001767418 F2 Capital I 2019, LLC C/O SINGER MCKEON INC, 8 WEST 38TH ST SUITE 1001 NEW YORK NY 10018 0 0 1 0 Common Stock 2019-02-19 4 C 0 1614515 A 1614515 I By Fund Common Stock 2019-02-19 4 C 0 193742 A 193742 I By Fund Common Stock 2019-02-19 4 C 0 410168 A 410168 I By Fund Common Stock 2019-02-19 4 C 0 282540 A 282540 I By Fund Common Stock 2019-02-19 4 C 0 403629 A 403629 I By Fund Common Stock 2019-02-19 4 P 0 200000 15.00 A 200000 I By Fund Common Stock 2019-02-19 4 P 0 166667 15.00 A 166667 I By Fund Common Stock 2019-02-19 4 P 0 166667 15.00 A 449207 I By Fund Common Stock 2019-02-19 4 P 0 133333 15.00 A 536962 I By Fund Series A Preferred Stock 2019-02-19 4 C 0 10000001 D Common Stock 1614515 0 I By Fund Series B Preferred Stock 2019-02-19 4 C 0 1200000 D Common Stock 193742 0 I By Fund Series B Preferred Stock 2019-02-19 4 C 0 2540500 D Common Stock 410168 0 I By Fund Series B Preferred Stock 2019-02-19 4 C 0 1750000 D Common Stock 282540 0 I By Fund Series B Preferred Stock 2019-02-19 4 C 0 2500000 D Common Stock 403629 0 I By Fund Each share of Series A Preferred Stock converted into shares of the Issuer's common stock, par value $0.0001 ("Common Stock"), on a 6.1938:1 basis upon the closing of the Issuer's initial public offering. The reported securities are owned directly by F2 Capital I 2015 Limited. Globeways Holdings Limited is the appointed manager of F2 Capital I 2015 Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Capital I 2015 Limited. Morana Jovan-Embiricos is the founding director of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein. Each share of Series B Preferred Stock converted into shares of the Issuer's Common Stock on a 6.1938:1 basis upon the closing of the Issuer's initial public offering.. The reported securities are owned directly by F2 Bioscience II 2017 Limited. Globeways Holdings Limited is the appointed manager of F2 Bioscience II 2017 Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Bioscience II 2017 Limited. Morana Jovan-Embiricos is the founding director of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein. The reported securities are owned directly by F2 Capital I 2017 Limited. Globeways Holdings Limited is the appointed manager of F2 Capital I 2017 Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Capital I 2017 Limited. Morana Jovan-Embiricos is the founding director of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein. The reported securities are owned directly by F2 MG Limited. Globeways Holdings Limited is the appointed manager of F2 MG Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 MG Limited. Morana Jovan-Embiricos is the founding director of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein. The reported securities are owned directly F2-TPO Investments, LLC. Globeways Holdings Limited is the appointed manager of F2-TPO Investments, LLC and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2-TPO Investments, LLC. Morana Jovan-Embiricos is the founding director of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein. The reported securities are owned directly by F2 BBG LLC. Globeways Holdings II Limited is the appointed manager of F2 BBG LLC and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 BBG LLC. Morana Jovan-Embiricos is the founding director of Globeways Holdings II Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings II Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein. The reported securities are owned directly by F2 Capital I 2019, LLC. Globeways Holdings II Limited is the appointed manager of F2 Capital I 2019, LLC and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Capital I 2019, LLC. Morana Jovan-Embiricos is the founding director of Globeways Holdings II Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings II Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein. /s/ Morana Jovan-Embiricos 2019-02-21 /s/ Rachel Hingham and Ivan Bedford for Globeways Holdings Limited 2019-02-21 /s/ Rachel Hingham and Ivan Bedford for Globeways Holdings II Limited 2019-02-21 /s/ Rachel Hingham and Ivan Bedford for F2 Capital I 2015 Limited 2019-02-21 /s/ Rachel Hingham and Ivan Bedford for F2 Bioscience II 2017 Limited 2019-02-21 /s/ Rachel Hingham and Ivan Bedford for F2 Capital I 2017 Limited 2019-02-21 /s/ Rachel Hingham and Ivan Bedford for F2 MG Limited 2019-02-21 /s/ Rachel Hingham and Ivan Bedford for F2-TPO Investments, LLC 2019-02-21 /s/ Rachel Hingham and Ivan Bedford for F2 BBG LLC 2019-02-21 /s/ Rachel Hingham and Ivan Bedford for F2 Capital I 2019, LLC 2019-02-21